摘要
Despite advances in colorectal cancer (CRC) treatment, most advanced CRC patients who experience disease progression after chemotherapy, targeted therapy, and immunotherapy face a situation in which there is no available medicine. Thus, new therapeutic drugs for CRC are urgently needed. Studies have shown that cholesteryl ester transfer protein (CETP) has a vital role in tumor development and is a possible target for CRC therapy. We found that Evacetrapib, a CETP inhibitor, suppressed CRC cell growth by inhibiting the Wnt/beta-catenin signaling pathway and activating the c-Jun NH2-terminal kinase (JNK) signaling pathway in CRC. Therefore, Evacetrapib displays an anti-cancer effect and is a possible option for treating CRC.
学科与关键词
关键词
Evacetrapibcolorectal cancerWntbeta-cateninc-Jun NH2-terminal kinasecholesteryl ester transfer protein
- Celastrol Inhibits the Proliferation and Induces Apoptosis of Colorectal Cancer Cells via Downregulating NF-κB/COX-2 Signaling PathwaysZhang, Hua; Zhao, Xiaojin; Shang, Fajun; Sun, Huan; Zheng, Xu; Zhu, Jiabin*Anti-Cancer Agents in Medicinal Chemistry, 2022, 22(10): 1921-1932.被引 4
- Cabazitaxel suppresses colorectal cancer cell growth via enhancing the p53 antitumor pathwayZhang, Wen; Sun, Ruiqian; Zhang, Yongjun; Hu, Rong; Li, Qian; Wu, Weili; Cao, Xinyu; Zhou, Jiajian; Pei, Jianfeng*; Yuan, Ping*FEBS Open Bio, 2021, 11(11): 3032-3050.被引 2
- Cannabidiol inhibits invasion and metastasis in colorectal cancer cells by reversing epithelial-mesenchymal transition through the Wnt/β-catenin signaling pathwayFeng, PanFeng; Zhu, LongXun; Jie, Jing; Yang, PengXiang; Sheng, Nan; Chen, XiangFan*; Chen, XiaJournal of Cancer Research and Clinical Oncology, 2023, 149(7): 3587-3598.被引 8
